Bloomage Biotechnology Corp Ltd
SSE:688363

Watchlist Manager
Bloomage Biotechnology Corp Ltd Logo
Bloomage Biotechnology Corp Ltd
SSE:688363
Watchlist
Price: 54 CNY -2.32% Market Closed
Market Cap: 26B CNY
Have any thoughts about
Bloomage Biotechnology Corp Ltd?
Write Note

Bloomage Biotechnology Corp Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bloomage Biotechnology Corp Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Bloomage Biotechnology Corp Ltd
SSE:688363
Cash & Cash Equivalents
ÂĄ623.6m
CAGR 3-Years
-21%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash & Cash Equivalents
ÂĄ15B
CAGR 3-Years
33%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash & Cash Equivalents
ÂĄ9.2B
CAGR 3-Years
27%
CAGR 5-Years
62%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash & Cash Equivalents
ÂĄ3.8B
CAGR 3-Years
75%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash & Cash Equivalents
ÂĄ5.6B
CAGR 3-Years
9%
CAGR 5-Years
38%
CAGR 10-Years
20%
Imeik Technology Development Co Ltd
SZSE:300896
Cash & Cash Equivalents
ÂĄ2.4B
CAGR 3-Years
-11%
CAGR 5-Years
56%
CAGR 10-Years
N/A
No Stocks Found

Bloomage Biotechnology Corp Ltd
Glance View

Market Cap
26B CNY
Industry
Biotechnology

Nestled in the bustling corridors of the biotechnology industry, Bloomage Biotechnology Corp Ltd. has carved a niche as a leading player specializing in the production and innovation of biopolymers, with a particular emphasis on hyaluronic acid. Since its inception, the company has embraced a scientific approach combined with a robust business strategy, propelling it to the forefront of biotechnological advancements. Its operations are underpinned by a relentless pursuit of research and development, utilizing cutting-edge fermentation technology to manufacture high-quality hyaluronic acid that serves various industries such as cosmetics, food, and pharmaceuticals. Bloomage’s revenue model is intricately linked to the diverse applications of hyaluronic acid. By supplying raw materials to cosmetic giants, the company significantly taps into the lucrative beauty industry, as this compound is highly valued for its skin hydration properties. Additionally, Bloomage is involved in the healthcare segment, where it provides key ingredients for medical products that enhance joint health and accelerate wound healing. Through strategic partnerships and a focus on high-margin products, Bloomage not only diversifies its revenue streams but also sustains its position in competitive markets. This deliberate orchestration of science and commerce ensures the company remains at the vanguard of both innovation and profitability.

Intrinsic Value
65.56 CNY
Undervaluation 18%
Intrinsic Value
Price

See Also

What is Bloomage Biotechnology Corp Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
623.6m CNY

Based on the financial report for Sep 30, 2024, Bloomage Biotechnology Corp Ltd's Cash & Cash Equivalents amounts to 623.6m CNY.

What is Bloomage Biotechnology Corp Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-2%

Over the last year, the Cash & Cash Equivalents growth was -45%. The average annual Cash & Cash Equivalents growth rates for Bloomage Biotechnology Corp Ltd have been -21% over the past three years , -2% over the past five years .

Back to Top